MX2019005217A - Process for obtaining polymer membranes from components of natural origin. - Google Patents
Process for obtaining polymer membranes from components of natural origin.Info
- Publication number
- MX2019005217A MX2019005217A MX2019005217A MX2019005217A MX2019005217A MX 2019005217 A MX2019005217 A MX 2019005217A MX 2019005217 A MX2019005217 A MX 2019005217A MX 2019005217 A MX2019005217 A MX 2019005217A MX 2019005217 A MX2019005217 A MX 2019005217A
- Authority
- MX
- Mexico
- Prior art keywords
- components
- natural origin
- polymer membranes
- obtaining polymer
- membranes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/18—Plasticising macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
- C08K5/092—Polycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/06—Pectin; Derivatives thereof
Abstract
A process for obtaining polymer membranes from components of natural origin, which comprise a cross-linked matrix of biomaterials having physical and mechanical properties for controlled loading and release of substances, preferably by means of diffusion. The membranes obtained have high biodegradability. Said membranes are used as controlled-release dosage forms of substances beneficial to human health applied topically.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/MX2019/000048 WO2020226476A1 (en) | 2019-05-03 | 2019-05-03 | Process for obtaining polymer membranes from components of natural origin |
MX2019005217A MX2019005217A (en) | 2019-05-03 | 2019-05-03 | Process for obtaining polymer membranes from components of natural origin. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2019005217A MX2019005217A (en) | 2019-05-03 | 2019-05-03 | Process for obtaining polymer membranes from components of natural origin. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019005217A true MX2019005217A (en) | 2020-11-04 |
Family
ID=73050816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019005217A MX2019005217A (en) | 2019-05-03 | 2019-05-03 | Process for obtaining polymer membranes from components of natural origin. |
Country Status (2)
Country | Link |
---|---|
MX (1) | MX2019005217A (en) |
WO (1) | WO2020226476A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2648278C (en) * | 2006-04-03 | 2019-05-28 | Isa Odidi | Drug delivery composition |
CN109276555A (en) * | 2018-11-15 | 2019-01-29 | 合肥华盖生物科技有限公司 | A kind of labile starch base Capsules of high-ductility |
-
2019
- 2019-05-03 WO PCT/MX2019/000048 patent/WO2020226476A1/en active Application Filing
- 2019-05-03 MX MX2019005217A patent/MX2019005217A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2020226476A1 (en) | 2020-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2017296095B2 (en) | Multispecific antibodies against CD40 and CD137 | |
SE1550189A1 (en) | Therapeutic and prophylactic composition produced by microbiota | |
BR112016029223A8 (en) | method for coating plant seeds, seed coating composition, coated plant seeds, use of one or more water-insoluble polymers, method of preparing a seed coating composition, method, use, composition or coated seed, use of an abrasive material and seed coating apparatus | |
MX2023006541A (en) | Fixed dose formulations. | |
BR112018000835A2 (en) | molecule, one or more polynucleotides, one or more vectors, cell, molecule production method, composition, use of the molecule, method of treating a disease and method for inducing lysis of a target cell | |
BR112018008625A2 (en) | processes for preparing a shaped porous carbon product and catalyst composition, shaped porous carbon product and catalyst composition. | |
MX2017001281A (en) | Anisotropic biocomposite material, medical implants comprising same and methods of treatment thereof. | |
MX342643B (en) | Pharmaceutical dosage forms comprising poly(e-caprolactone). | |
MX2018002906A (en) | Methods of treating developmental disorders using pipradrol. | |
MX2019009566A (en) | Proteins binding bcma, nkg2d and cd16. | |
CL2008002486A1 (en) | Divisible modified release tablet comprising glycanzide, a cellulose derivative chosen from: hmc, hec, hpc and / or hpmc and a binder chosen from: maltodextrin, polyvinone or hpmc; Use to treat diabetes. | |
NZ729417A (en) | Compositions and methods for enhancing healing and regeneration of bone and soft tissue | |
PH12019501199A1 (en) | Calcium lactate compositions and methods of use | |
MX2021010827A (en) | Plant based functional materials. | |
AR122018A1 (en) | NKG2D, CD16 AND CLEC12A BINDING PROTEINS | |
AR120223A1 (en) | PROTEINS BINDING NKG2D, CD16 AND FLT3 | |
MX2022006817A (en) | Formulations/compositions comprising a btk inhibitor. | |
CO2020001981A2 (en) | Proteins that bind to nkg2d, cd16, and flt3 | |
BR112022017305A2 (en) | MULTI-SPECIFIC ANTIGEN-BINDING MOLECULES TARGETING CLAUDIN-6 AND USES THEREOF | |
BR112016022117A2 (en) | METHOD OF PRODUCTION OF A BRANCHED POLYMER, BRANCHED POLYMER AND USES OF SUCH POLYMER | |
NZ763301A (en) | Adaptation of hollow-fiber-based cell culture technology for the manufacturing of neo-islets or exosomes from stem cells | |
BR112018000841A2 (en) | 5-hydroxytryptamine1b receptor stimulating agent for use as a satellite cell self-renewal and / or differentiation promoter | |
MX2019010228A (en) | Composition for controlled release of physiologically active substances and process for its preparation. | |
BR112017014017A2 (en) | systems and methods for improved distribution of osteoinductive molecules in bone repair. | |
MX2019005217A (en) | Process for obtaining polymer membranes from components of natural origin. |